MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Tics(also see Gilles de la Tourette syndrome): Clinical features"

  • 2025 International Congress

    From Subclinical Symptoms to Post-Surgical Challenges: A Pediatric Case of Craniopharyngioma

    M. Gomez Rodriguez, H. Torocsik (Pembroke Pines, USA)

    Objective: To provide a case of subclinical symptoms including motor tics in a child found to have a large craniopharyngioma with post surgical parkinsonism. Background:…
  • 2025 International Congress

    Increased Health Care Utilization in Children/Adolescents With Tourette Syndrome Treated With Dopamine D2 Receptor Antagonists: An Electronic Medical Records Database Analysis

    D. Isaacs, J. Swindle, F. Dabbous, G. Karkanias, S. Atkinson, F. Munschauer, F. Mazhar, C. Pettersson, S. Wanaski, T. Cunniff, K. Tomczak (Nashville, USA)

    Objective: To compare health care resource utilization (HCRU) in dopamine D2 receptor antagonist (D2RA)-exposed versus D2RA non-exposed individuals with Tourette syndrome (TS). Background: TS is…
  • 2025 International Congress

    Determination of the Minimal Clinically Important Difference in the Yale Global Tic Severity Scale Total Tic Score in a Pediatric Population With Tourette Syndrome Receiving Pharmacotherapy

    J. Mcguire, G. Karkanias, R. Bittman, S. Atkinson, F. Munschauer, S. Wanaski, T. Cunniff, D. Gilbert (Baltimore, USA)

    Objective: The aim was to determine the minimal clinically important difference (MCID) on the Yale Global Tic Severity Scale (YGTSS), using the Clinical Global Impression…
  • 2025 International Congress

    Real-World Adverse Event Profile in Children and Adolescents With Tourette Syndrome Treated With Dopamine D2 Receptor Antagonists (D2RAs) Compared With Non-D2RAs

    K. Tomczak, J. Swindle, F. Dabbous, G. Karkanias, S. Atkinson, F. Munschauer, F. Mazhar, C. Pettersson, S. Wanaski, T. Cunniff, D. Isaacs (Bethesda, USA)

    Objective: To further explore the safety profile of dopamine D2 receptor antagonists (D2RAs) for Tourette syndrome (TS) in a community setting. Background: D2RAs (aripiprazole/haloperidol/pimozide) are…
  • 2025 International Congress

    Clinical Characteristics and Antipsychotic Medication Use in Pediatric Population Diagnosed With Tourette Syndrome

    K. Tomczak, J. Swindle, F. Dabbous, G. Karkanias, S. Atkinson, F. Munschauer, F. Mazhar, C. Pettersson, S. Wanaski, T. Cunniff, D. Isaacs (Boston, USA)

    Objective: To assess the clinical characteristics and rate of antipsychotic medication discontinuation in a pediatric cohort diagnosed with Tourette syndrome (TS). Background: It is estimated…
  • 2025 International Congress

    Efficacy and Safety of Ecopipam for Tourette Syndrome (TS): Results From a Phase 3, Randomized, Double-Blind, Placebo-Controlled Withdrawal Trial

    K. Tomczak, S. Atkinson, D. Kim, M. Miller, P. Rice, G. Karkanias, F. Munschauer, S. Wanaski, T. Cunniff, D. Gilbert (Chicago, USA)

    Objective: To evaluate the efficacy and safety of ecopipam, a dopamine D1 receptor antagonist, as a maintenance therapy in children, adolescents, and adults with TS.…
  • 2025 International Congress

    Sensory sensitivities in individuals with Tics and Tourette Syndrome

    R. Burke, I. Malaty (Gainesville, USA)

    Objective: We aim to review patterns of sensory sensitivity in patients with tics and Tourette's syndrome to gain insight into this under-reported phenomenon. Background: Patients…
  • 2025 International Congress

    STOP-TIC Study: Strengthening Tourette Treatment Options using TMS to Improve CBIT, a randomized sham-controlled trial

    J. Frey, J. Sherman, T. Mcgaughey, J. Suffridge, M. Khan, E. Reid, U. Najib, A. Wagle Shukla, A. Murray, M. Okun, IA. Malaty (Morgantown, USA)

    Objective: To determine if accelerated repetitive transcranial magnetic stimulation (rTMS) administered prior to Comprehensive Behavioral Intervention for Tics (CBIT) will improve tics in Tourette Syndrome…
  • 2025 International Congress

    Aversions as Triggers for Tic Exacerbations

    M. Siegel, P. Graese, I. Malaty (Gainesville, USA)

    Objective: We report three cases of Tourette syndrome wherein aversions were extreme triggers for tics. These mundane sensory stimuli provoked intense tic exacerbation. Background: Tic…
  • 2025 International Congress

    MDS Task Force on Tic Disorders: Development of a New Classification Scheme for Tic Disorders

    I. Malaty, K. Bhatia, K. Black, F. Cardoso, D. Gilbert, M. Hallett, J. Jimenez-Shahed, D. Martino, A. Munchau, M. Okun, P. Pal, J. Piacentini, T. Pringsheim, Y. Worbe, C. Ganos (London, United Kingdom)

    Objective: To establish a clear definition and axis classification scheme for tics that serves to separate phenomenology from etiology. Background: Gilles de la Tourette documented…
  • 1
  • 2
  • 3
  • …
  • 7
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley